palvella Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
353 W Lancaster Ave Ste 200, Wayne, Penn...Phone Number
(484) 253-1461Website
www.palvellatx.comRevenue
-Stock Symbol
PVLAIndustry
About palvella Therapeutics
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients affected by serious rare genetic skin disorders and vascular diseases that currently have limited or no approved treatment options. The company focuses on advancing precision medicines designed to address conditions that significantly affect patients' quality of life while often lacking effective therapeutic alternatives. Through scientific innovation, clinical research, and targeted drug development, Palvella Therapeutics seeks to transform the treatment landscape for underserved patient populations living with debilitating dermatological and vascular disorders.Explore more
palvella Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to palvella Therapeutics
Compare insights from companies similar to palvella Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
palvella Therapeutics Tech Stack
A closer look at the technologies used by palvella Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding palvella Therapeutics
Sign Up For FreeTo access detailed company insights
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients affected by serious rare genetic skin disorders and vascular diseases that currently have limited or no approved treatment options. The company focuses on advancing precision medicines designed to address conditions th... Read More
